Precautionary Principle under the Cartagena Protocol on Transboundary Movement of LMOs

Ansari, Abdul Haseeb; Wartini, Sri
April 2013
Advances in Environmental Biology;Apr2013, Vol. 7 Issue 4, p636
Academic Journal
The Cartagena Protocol, made under the Convention on Biological Diversity, aims at protecting the 'human, animal and plant life and health' by prescribing a high standard of precautionary principle. This has to be based on risk assessment. Thus, the importing countries of GMOs/LMOs have the right to invoke the precautionary principle provisions enshrined in the Cartagena Protocol and the exporting countries have to provide required relevant information. This is working well. However, there are certain controversial legal and ethical aspects that require to be revisited and have to be amicably settled so that there could be wider acceptability of the precautionary principle. It has been observed that a large number of states prefer international trade in GMOs/LMOs over protection of human health and the environment, some countries for a short-term economic gain ignore this aspect. Likewise, some scientists for the sake of name and fame or quick hauling of money, wish to introduce GMOs produced by them. The paper thoroughly discusses these and offers certain amicable solutions to them.


Related Articles

  • COP/MOP 7 HIGHLIGHTS WEDNESDAY, 1 OCTOBER 2014.  // Earth Negotiations Bulletin;10/2/2014, Vol. 9 Issue 633, p1 

    The article offers information on the seventh meeting of the Conference of the Parties/Meeting of the Parties (COP/MOP 7) on October 1, 2014. Topics discussed include biosafety, response to biodiversity damage, and transboundary transfer of living modified organisms (LMOs). The meeting featured...

  • Precautionary Principle under the SPS Agreement: A Critical Exposition. Ansari, Abdul Haseeb; Wartini, Sri // Advances in Environmental Biology;Apr2013, Vol. 7 Issue 4, p633 

    The Sanitary and Phytosanitary Agreement of 1992, which is a part of the WTO legal regime, in order to ensure augment international trade in GMOs, provides for ensuring their safety so that they could be acceptable in international market, i.e. it prescribes for a kind of precautionary...

  • Why reinvent risk? Lee, Robert C. // Nature Biotechnology;Mar2003, Vol. 21 Issue 3, p229 

    Reacts to two commentaries in the November 2002 issue of 'Nature Biotechnology' regarding risk assessment and precautionary principle as applied to genetically modified organisms (GMO). Reactor's view that neither authors made a distinction between the scientific and analytical process of risk...

  • Socio-economic Considerations under the Cartagena Protocol on Biosafety: Insights for Effective Implementation. Catacora-Vargas, Georgina // Asian Biotechnology & Development Review;Nov2012, Vol. 14 Issue 3, p1 

    The inclusion of the socio-economic aspects in environmental decision-making has been practiced since the early seventies. The interactions between the environment and society, the growing demand for social responsibility and the pledge towards sustainable development are some of its drivers....

  • COP/MOP 7 HIGHLIGHTS THURSDAY, 2 OCTOBER 2014.  // Earth Negotiations Bulletin;10/3/2014, Vol. 9 Issue 634, p1 

    The article offers information on the seventh meeting of the Conference of the Parties/Meeting of the Parties (COP/MOP 7) on October 2, 2014. Topics discussed include the efficacy of the processes and structures of the COP-MOP convention, the revision on Biosafety Clearing-House (BCH) decisions,...

  • Time to settle the synthetic controversy. ter Meulen, Volker // Nature;5/8/2014, Vol. 509 Issue 7499, p135 

    The article reflects on the issues regarding the use of synthetic biology by scientist to deliver benefits to society, as of May 2014. Topics include the Conference of the Parties to the Convention on Biological Diversity (CBD) on the impact of synthetic biology on biodiversity, the publication...

  • Executive summary.  // Human & Experimental Toxicology;Sep/Oct2002, Vol. 21 Issue 9/10, p469 

    Presents a summary of the proceedings of the 'Developmental Immunitoxicology and Risk Assessment' workshop held on June 12 to 13, 2002 in Washington D.C. Workshop's goal of examining scientific questions that underlie developmental immunotoxicity tests and the interpretations of the results as...

  • Development immunotoxicology and risk assessment: a workshop summary. Holsapple, M.P. // Human & Experimental Toxicology;Sep/Oct2002, Vol. 21 Issue 9/10, p473 

    A workshop entitled 'Developmental Immunotoxicology and Risk Assessment' was held on 12-13 June 2001, in Washington, DC. The workshop was organized jointly by the Immunotoxicology Technical Committee (ITC) of the International Life Sciences Institute's" (ILSI) Health and Environmental Sciences...

  • Taking European Clinical Expertise to Africa. O'Donnell, Peter // Applied Clinical Trials;Nov2002, Vol. 11 Issue 11, p24 

    Reports on the formation of clinical trials partnership between various European Union member states, the pharmaceutical industry and developing countries to combat poverty-linked diseases at the World Summit on Sustainable Development held in 2001 at Johannesburg, South Africa. Measures to...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics